- Home
- ARCT vs PFL Comparison
ARCT vs PFL Comparison
Compare ARCT & PFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- PFL
- Stock Information
- Founded
- ARCT 2013
- PFL 2003
- Country
- ARCT United States
- PFL United States
- Employees
- ARCT N/A
- PFL N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- PFL Finance Companies
- Sector
- ARCT Health Care
- PFL Finance
- Exchange
- ARCT Nasdaq
- PFL Nasdaq
- Market Cap
- ARCT 320.8M
- PFL 374.5M
- IPO Year
- ARCT N/A
- PFL N/A
- Fundamental
- Price
- ARCT $19.48
- PFL $8.46
- Analyst Decision
- ARCT Strong Buy
- PFL
- Analyst Count
- ARCT 8
- PFL 0
- Target Price
- ARCT $48.83
- PFL N/A
- AVG Volume (30 Days)
- ARCT 648.4K
- PFL 113.7K
- Earning Date
- ARCT 08-11-2025
- PFL 01-01-0001
- Dividend Yield
- ARCT N/A
- PFL 11.53%
- EPS Growth
- ARCT N/A
- PFL N/A
- EPS
- ARCT N/A
- PFL N/A
- Revenue
- ARCT $122,122,000.00
- PFL N/A
- Revenue This Year
- ARCT N/A
- PFL N/A
- Revenue Next Year
- ARCT $37.73
- PFL N/A
- P/E Ratio
- ARCT N/A
- PFL N/A
- Revenue Growth
- ARCT N/A
- PFL N/A
- 52 Week Low
- ARCT $8.04
- PFL $6.98
- 52 Week High
- ARCT $25.88
- PFL $8.62
- Technical
- Relative Strength Index (RSI)
- ARCT 75.39
- PFL 56.74
- Support Level
- ARCT $11.27
- PFL $8.41
- Resistance Level
- ARCT $19.99
- PFL $8.50
- Average True Range (ATR)
- ARCT 1.31
- PFL 0.05
- MACD
- ARCT 0.79
- PFL -0.00
- Stochastic Oscillator
- ARCT 94.15
- PFL 53.57
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.
About PFL PIMCO Income Strategy Fund Shares of Beneficial Interest
PIMCO Income Strategy Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek high current income, consistent with the preservation of capital. It seeks to achieve its objectives by investing in a diversified portfolio of floating and fixed-rate debt instruments.